AstraZeneca builds case for long-acting COVID-19 drug, but is it too late?
In some ways, AstraZeneca's COVID-19 response has been as good as any in the biopharmaceutical industry.
The British drugmaker licensed and developed an effective CO...
Continue Reading →
